Gastrointestinal Diseases  >>  Mifeprex (mifepristone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mifeprex (mifepristone) / Danco Laboratories
NCT00255177: Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients

Completed
2
44
US
VGX-410 (Mifepristone), Mifepristone, Placebo
VGX Pharmaceuticals, LLC
Hepatitis C Virus Infection
09/07
01/08
NCT00459290: Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Completed
2
24
US
mifepristone
Gynecologic Oncology Group
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
07/10
07/10

Download Options